Correlation Between TRACON Pharmaceuticals and Monopar Therapeutics

Can any of the company-specific risk be diversified away by investing in both TRACON Pharmaceuticals and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TRACON Pharmaceuticals and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between TRACON Pharmaceuticals and Monopar Therapeutics, you can compare the effects of market volatilities on TRACON Pharmaceuticals and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TRACON Pharmaceuticals with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of TRACON Pharmaceuticals and Monopar Therapeutics.

Diversification Opportunities for TRACON Pharmaceuticals and Monopar Therapeutics

0.0

Correlation Coefficient

TRACON Pharmaceuticals  Monopar Therapeutics

Pay attention - limited upside

The 3 months correlation between TRACON and Monopar is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding TRACON Pharmaceuticals and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and TRACON Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TRACON Pharmaceuticals are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of TRACON Pharmaceuticals i.e., TRACON Pharmaceuticals and Monopar Therapeutics go up and down completely randomly.

Pair Corralation between TRACON Pharmaceuticals and Monopar Therapeutics

If you would invest  2,201  in Monopar Therapeutics on December 1, 2024 and sell it today you would earn a total of  1,310  from holding Monopar Therapeutics or generate 59.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

TRACON Pharmaceuticals  vs.  Monopar Therapeutics

TRACON Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days TRACON Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, TRACON Pharmaceuticals is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Monopar Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with TRACON Pharmaceuticals and Monopar Therapeutics

The main advantage of trading using opposite TRACON Pharmaceuticals and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TRACON Pharmaceuticals position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.

The idea behind TRACON Pharmaceuticals and Monopar Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.